Early cross-coronavirus reactive signatures of protective humoral immunity against COVID-19

The introduction of vaccines has inspired new hope in the battle against SARS-CoV-2. However, the emergence of viral variants, in the absence of potent antivirals, has left the world struggling with the uncertain nature of this disease. Antibodies currently represent the strongest correlate of immun...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaplonek, Paulina, Wang, Chuangqi, Bartsch, Yannic, Fischinger, Stephanie, Gorman, Matthew J., Bowman, Kathryn, Kang, Jaewon, Dayal, Diana, Martin, Patrick, Nowak, Radoslaw, Hsieh, Ching-Lin, Feldman, Jared, Julg, Boris, Nilles, Eric J., Musk, Elon R., Menon, Anil S., Fischer, Eric S., McLellan, Jason S., Schmidt, Aaron, Goldberg, Marcia B., Filbin, Michael, Hacohen, Nir, Lauffenburger, Douglas A, Alter, Galit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132219/
https://www.ncbi.nlm.nih.gov/pubmed/34013263
http://dx.doi.org/10.1101/2021.05.11.443609

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132219/
https://www.ncbi.nlm.nih.gov/pubmed/34013263
http://dx.doi.org/10.1101/2021.05.11.443609

Ejemplares similares